Literature DB >> 17457097

Pregnancy and the risk of HIV-1 acquisition among women in Uganda and Zimbabwe.

Charles S Morrison1, Jing Wang, Barbara Van Der Pol, Nancy Padian, Robert A Salata, Barbra A Richardson.   

Abstract

OBJECTIVE: Several studies have suggested that pregnancy is associated with an increased risk of HIV-1 acquisition. We used data from a large, prospective study of hormonal contraception and HIV-1 to evaluate the effect of pregnancy on the risk of HIV-1 acquisition.
DESIGN: A multicenter prospective cohort study.
METHODS: We examined 4439 women from family planning sites in Uganda and Zimbabwe contributing 31 369 follow-up visits during 1999-2004. Participants were aged 18-35 years, and had received pregnancy and HIV-1 testing quarterly for 15-24 months. Using proportional hazards modeling, we compared the time to HIV-1 acquisition among four groups: pregnant women, non-pregnant lactating (NP/L) women, and women neither pregnant nor lactating (NP/NL) who were either using or not using hormonal contraception.
RESULTS: A total of 211 participants became HIV-1 infected (2.7 per 100 woman-years; wy), including 13 pregnant women (1.6 per 100 wy), 33 NP/L women (2.7 per 100 wy), 126 NP/NL women using hormonal contraception (2.9 per 100 wy), and 39 NP/NL women not using hormonal contraception (2.7 per 100 wy). In multivariable analysis adjusting for site, age, living with partner, risky sexual behaviors, and incident vaginal, cervical and herpes simplex virus 2 infections, neither pregnant, NP/L, nor NP/NL women using hormonal contraception were at an increased risk of HIV-1 acquisition compared with NP/NL women not using hormonal contraception.
CONCLUSION: Neither pregnancy nor lactation placed women at increased risk of HIV-1 acquisition in this multisite, prospective study of African women. This information is important in planning interventions to reduce HIV-1 acquisition among women.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17457097     DOI: 10.1097/QAD.0b013e3280f00fc4

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  28 in total

1.  In vitro anti-HIV-1 activity in cervicovaginal secretions from pregnant and nonpregnant women.

Authors:  Brenna L Anderson; Mimi Ghosh; Christina Raker; John Fahey; Yan Song; Dwight J Rouse; Charles R Wira; Susan Cu-Uvin
Journal:  Am J Obstet Gynecol       Date:  2012-04-30       Impact factor: 8.661

2.  The impact of pregnancy on anti-HIV activity of cervicovaginal secretions.

Authors:  Brenna L Hughes; Riana Dutt; Christina Raker; Melody Barthelemy; Richard M Rossoll; Bharat Ramratnam; Charles R Wira; Susan Cu-Uvin
Journal:  Am J Obstet Gynecol       Date:  2016-07-05       Impact factor: 8.661

Review 3.  Clinical parameters essential to methodology and interpretation of mucosal responses.

Authors:  Brenna L Anderson; Susan Cu-Uvin
Journal:  Am J Reprod Immunol       Date:  2011-01-12       Impact factor: 3.886

4.  Performing Drug Safety Research During Pregnancy and Lactation: Biomedical HIV Prevention Research as a Template.

Authors:  Richard H Beigi; Lisa Noguchi; Gina Brown; Jeanna Piper; D Heather Watts
Journal:  J Womens Health (Larchmt)       Date:  2013-06-29       Impact factor: 2.681

5.  A prospective study of the effect of pregnancy on CD4 counts and plasma HIV-1 RNA concentrations of antiretroviral-naive HIV-1-infected women.

Authors:  Renee Heffron; Deborah Donnell; James Kiarie; Helen Rees; Kenneth Ngure; Nelly Mugo; Edwin Were; Connie Celum; Jared M Baeten
Journal:  J Acquir Immune Defic Syndr       Date:  2014-02-01       Impact factor: 3.731

6.  Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling.

Authors:  Charles S Morrison; Pai-Lien Chen; Cynthia Kwok; Barbra A Richardson; Tsungai Chipato; Roy Mugerwa; Josaphat Byamugisha; Nancy Padian; David D Celentano; Robert A Salata
Journal:  AIDS       Date:  2010-07-17       Impact factor: 4.177

7.  The contribution of maternal HIV seroconversion during late pregnancy and breastfeeding to mother-to-child transmission of HIV.

Authors:  Leigh F Johnson; Kathryn Stinson; Marie-Louise Newell; Ruth M Bland; Harry Moultrie; Mary-Ann Davies; Thomas M Rehle; Rob E Dorrington; Gayle G Sherman
Journal:  J Acquir Immune Defic Syndr       Date:  2012-04-01       Impact factor: 3.731

8.  Increases in human papillomavirus detection during early HIV infection among women in Zimbabwe.

Authors:  Rebecca G Nowak; Patti E Gravitt; Charles S Morrison; Stephen J Gange; Cynthia Kwok; Amy E Oliver; Roslyn Howard; Barbara Van der Pol; Robert A Salata; Nancy S Padian; Tsungai Chipato; Marshall Munjoma; David D Celentano
Journal:  J Infect Dis       Date:  2011-04-15       Impact factor: 5.226

9.  Pregnancy, contraceptive use, and HIV acquisition in HPTN 039: relevance for HIV prevention trials among African women.

Authors:  Stewart E Reid; James Y Dai; Jing Wang; Bupe N Sichalwe; Godspower Akpomiemie; Frances M Cowan; Sinead Delany-Moretlwe; Jared M Baeten; James P Hughes; Anna Wald; Connie Celum
Journal:  J Acquir Immune Defic Syndr       Date:  2010-04       Impact factor: 3.731

10.  A little bit pregnant: modeling how the accurate detection of pregnancy can improve HIV prevention trials.

Authors:  Courtney A Schreiber; Mary Sammel; Sharon L Hillier; Kurt T Barnhart
Journal:  Am J Epidemiol       Date:  2008-12-18       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.